What Is the Life Expectancy With an Aortic Aneurysm?

Life expectancy with an aortic aneurysm depends heavily on where in the aorta it sits, how large it is, and whether it gets repaired. A small, stable aneurysm found early and monitored closely may never shorten your life at all. A large, fast-growing one left untreated carries grim odds. Older population studies of untreated abdominal aortic aneurysms found five-year survival as low as 15 to 51 percent, while patients who undergo successful elective repair can, in some age groups, reach a lifespan comparable to the general population. The range is enormous because “aortic aneurysm” describes a spectrum, not a single condition.

What Happens Without Treatment

The natural history of an untreated aortic aneurysm is shaped mostly by two competing threats: the aneurysm rupturing and the cardiovascular disease that usually accompanies it. In a population-based study of 187 patients diagnosed with abdominal aortic aneurysms (AAAs) over a nine-year span, overall five-year survival was about 51 percent, with a trend toward worse outcomes in those with larger aneurysms.¹ A smaller study of 63 patients managed without surgery found far bleaker numbers: half were dead within two years, and five-year survival was only about 15 percent, with rupture as the leading cause of death and an annual rupture risk around 7 percent.²

These numbers reflect older cohorts whose aneurysms were often large at the time of diagnosis. Today, with screening and imaging more widely available, many aneurysms are caught when they are small and still growing slowly. Small aneurysms (under about 5.5 cm in the abdomen) are usually watched rather than immediately repaired, and many patients in that category live for years without incident. The danger escalates as the aneurysm grows.

For thoracic aortic aneurysms (TAAs), the picture is somewhat different. A study tracking untreated TAAs found that the risk of death climbed steeply with both baseline size and how fast the aneurysm was growing, with the hazard of death roughly doubling for every additional centimeter of diameter.³ Patients with ascending aortic aneurysms and descending thoracic aneurysms tended to survive longer than those with abdominal aneurysms when left untreated, though size and specialist oversight were major factors in both.⁴

How Size Drives Rupture Risk

Aneurysm diameter is still the single most influential factor doctors use to decide when to intervene. For abdominal aneurysms, the widely used threshold is about 5.5 cm in men, at which point elective repair is typically recommended. But the 5.5 cm cutoff is a rough guide, not a bright line. Autopsy data have shown that roughly 13 percent of AAAs with a diameter of 5 cm or less had already ruptured, while about 60 percent of those larger than 5 cm never did.⁵ In other words, size matters, but it is far from the whole story.

For AAAs in the 55–59 mm range, estimated annual rupture rates are roughly 1 percent for men and a bit higher for women. At 60–69 mm the rates climb to about 2.4 percent per year for men and nearly 7 percent for women.⁶ The sex difference here is real and discussed further below.

Thoracic aneurysms follow a similar size-dependent pattern but with different thresholds. For descending thoracic aneurysms, the risk of a serious aortic event (rupture or dissection) within one year was estimated at about 5.5 percent at a diameter of 50 mm and over 9 percent at 60 mm.⁷ When thoracic aneurysms exceed 6 cm, annual rupture rates reach about 3.7 percent and the combined rate of rupture, dissection, or death hits roughly 15.6 percent per year, with a 27-fold increase in rupture odds compared with smaller aneurysms.⁸

How Repair Changes the Outlook

Elective repair, whether done through traditional open surgery or through a catheter-based approach (endovascular repair, or EVAR for abdominal and TEVAR for thoracic aneurysms), dramatically improves survival compared with leaving a large aneurysm alone. The key question for patients is not whether to fix a large aneurysm but which method to use and when.

For abdominal aneurysms, large randomized trials have compared EVAR with open repair. A meta-analysis pulling together data from the major trials found that long-term survival was essentially identical between the two approaches: relative survival at 3, 5, and 10 years was about 94–96 percent, 91 percent, and 76 percent, respectively, regardless of which technique was used.⁹ EVAR tends to offer a survival edge in the first few months after the procedure because it is less physically punishing, but that early advantage fades. The UK EVAR Trial 1, with over 12 years of follow-up, found that beyond eight years open repair actually had lower total and aneurysm-related death rates.¹⁰ A separate long-term trial showed a similar pattern of the two approaches trading small, non-significant advantages over different time windows, ultimately converging on comparable survival.¹¹

For thoracic aneurysms, direct randomized comparisons are fewer. An observational study of Medicare patients found that open repair of intact thoracic aneurysms had better five-year survival (about 72 percent) than endovascular repair (about 62 percent), even after adjusting for patient differences.¹² However, a single-center study with longer follow-up found no significant survival difference at 10 years, with predictors of late death being patient factors like lung disease, diabetes, and kidney problems rather than the type of repair itself.¹³ The difference between these findings likely reflects patient selection: sicker patients who cannot tolerate open surgery are steered toward TEVAR, which muddies direct comparisons from observational data.

One encouraging finding is that patients over 80 who undergo successful elective repair can reach a lifespan comparable to their peers in the general population. A German study comparing post-repair survival with age- and sex-matched expected survival found no significant shortfall.¹⁴ That does not mean every 80-year-old should be operated on, but it does suggest that when the patient is fit enough for elective repair, the aneurysm itself need not cut life short.

Endoleaks and the Need for Lifelong Monitoring After EVAR

One reason the long-term calculus around EVAR is complicated is endoleaks, blood flow that persists around or through the stent graft and continues to pressurize the aneurysm sac. About 16 percent of patients in one large registry had an endoleak detected during follow-up.¹⁵ Not all endoleaks are equal. The most common type, called a type II endoleak (blood feeding backward into the sac from branch arteries), does not appear to affect long-term survival and often seals on its own.¹⁶ More serious leaks at the attachment sites of the graft (type I) or through the graft material (type III) are rarer but do reduce five-year survival and often require a second procedure.¹⁵

This is why EVAR patients need periodic imaging, usually CT scans, for the rest of their lives. If you stop showing up for those scans and a problem develops silently, the consequences can be serious. In one study, more than 40 percent of EVAR patients were eventually lost to follow-up entirely.¹⁷ The long-term commitment to monitoring is worth weighing when choosing between open and endovascular repair.

Why Women Face Worse Odds

Aortic aneurysms are far more common in men, but women who do develop them tend to fare worse at nearly every stage. Among untreated patients with intact AAAs, rupture occurred in about 9.7 percent of women versus 6.9 percent of men over five years, and being female was an independent predictor of rupture after adjusting for other factors.¹⁸ Women’s aortas are smaller to begin with, so the same absolute diameter may represent a proportionally larger bulge, which is one reason some experts argue the repair threshold should be lower for women than the standard 5.5 cm.

If an aneurysm does rupture, women have higher in-hospital mortality regardless of whether they undergo open or endovascular repair. A large analysis found in-hospital death rates of about 34 percent for women versus 27 percent for men, and that gap persisted after adjusting for age, comorbidities, and repair type. Eight-year survival after ruptured AAA repair was roughly 37 percent for women compared with 50 percent for men.¹⁹ For elective intact repairs, the picture is more mixed. In one registry, women had higher 30-day mortality after open repair for both intact and ruptured aneurysms, but mortality after elective EVAR was essentially the same for men and women. After controlling for all relevant factors, sex alone was not an independent predictor of death.²⁰ That hints that much of the survival gap may come from women presenting later, having smaller vessels that make surgery technically harder, and being underrepresented in screening programs.

The Cardiovascular Shadow Behind the Aneurysm

An aortic aneurysm is rarely an isolated problem. It is a marker of widespread vascular disease. Even after successful repair, people with aortic aneurysms die of heart attacks and strokes at elevated rates. Research tracking patients before and after surgery found that each additional 0.8 cm of aneurysm diameter at baseline was associated with about a 30 percent increase in the risk of cardiovascular death, independent of the aneurysm itself ever rupturing.²¹ This means that even a perfectly repaired aneurysm does not erase the underlying cardiovascular risk that caused it.

This is one reason managing blood pressure, cholesterol, and smoking cessation matter just as much as the aneurysm itself. Statin medications have drawn particular interest. A systematic review found that statin use was linked to slower AAA growth by roughly 0.8 mm per year, a 37 percent reduction in rupture risk, and lower perioperative mortality when patients did go to surgery.²² A separate meta-analysis confirmed a lower growth rate and showed that statin use was associated with reduced short-term and long-term mortality after AAA repair.²³ Post-repair statin use was also associated with a meaningful long-term survival benefit in a large British study.²⁴ These are observational findings, so they do not prove statins caused the improvement, but the consistency across studies makes a strong case for their routine use in aneurysm patients.

When Rupture Actually Happens

A ruptured aortic aneurysm is one of the most lethal surgical emergencies. Many people who rupture never make it to a hospital. Among those who do reach the operating room, mortality is brutally high. In one analysis, overall in-hospital mortality for ruptured AAA repair was 42 percent. The risk rose steeply with age, pre-existing kidney disease, loss of consciousness, and cardiac arrest: patients with all four of those factors had an 89 percent chance of dying in the hospital.²⁵ Even with zero additional risk factors, in-hospital mortality was about 11 percent, and that only counts people who survived long enough to undergo surgery.

This is the fundamental reason that screening and elective repair exist: catching and fixing the aneurysm before it ruptures avoids a catastrophic event that carries worse odds than many cancers. Meta-analyses of screening programs in men have shown that population-based ultrasound screening reduces both aneurysm-related death and overall mortality.²⁶ A more recent meta-analysis estimated that screening cut aneurysm-related mortality by about 35 percent and reduced the rate of emergency repair.²⁷ In most countries, one-time screening is recommended for men who have ever smoked and are 65 or older. Women are not routinely screened, which may contribute to the worse outcomes discussed earlier.

Aneurysm Shape and Location Matter Too

Not all aneurysms look the same on imaging. The familiar balloon-like bulge that expands the aorta symmetrically in all directions is called fusiform. A less common type, the saccular aneurysm, bulges outward from just one side. Saccular aneurysms tend to rupture at smaller sizes. In a Japanese national database, saccular abdominal aneurysms ruptured at a median diameter of about 56 mm, compared with 68 mm for fusiform ones. In the 40–54 mm range, saccular shape was an independent risk factor for rupture, with odds roughly 2.5 times higher.²⁸ A Dutch study confirmed that saccular AAAs present acutely at smaller diameters and that a quarter of saccular aneurysms requiring emergency treatment had a diameter below 55 mm.²⁹

This matters for your prognosis because the standard size thresholds used for deciding on surgery were built largely from data on fusiform aneurysms. If your imaging shows a saccular shape, your surgeon may recommend repair at a smaller diameter than usual. Researchers are also working on computational tools that estimate wall stress and rupture probability for an individual patient’s anatomy, which could eventually replace the blunt diameter threshold with a more personalized risk assessment.³⁰

Marfan Syndrome and Connective Tissue Disorders

People with inherited connective tissue disorders like Marfan syndrome develop aortic aneurysms much earlier in life, often in their twenties or thirties. Historically, Marfan syndrome carried a grim prognosis: in 1972, median survival was about 48 years. By the early 1990s, that had jumped to around 72 years, driven by advances in cardiac surgery, earlier diagnosis, and the use of beta-blocker medications.³¹ Among surgically treated Marfan patients, the ten-year survival probability was about 70 percent, and median life expectancy after aortic aneurysm repair was around 61 years, significantly better than the 47-year median reported a generation earlier.³²

For Marfan patients, the aortic root diameter is the dominant variable shaping life expectancy. A decision analysis found that a patient with a 3 cm aortic root, no recent growth, and no family history of aortic dissection had a modeled life expectancy of about 74 years on medical therapy alone. That number dropped as the root enlarged, with root diameter having a bigger impact than either growth rate or family history on projected survival.³³ One important caveat: Marfan syndrome is a disease of the entire aorta, and over half of patients who have their ascending aorta repaired eventually need surgery at other sites along the aorta.³²

Frailty, Fitness, and Socioeconomic Factors

How fit you are going into surgery may matter as much as the aneurysm itself. A meta-analysis examining frailty and muscle loss (sarcopenia) in patients undergoing elective EVAR found that frail patients had roughly five times the 30-day mortality risk and about 2.4 times the risk of death over the long term compared with non-frail patients.³⁴ This is why many vascular surgery teams now assess frailty before recommending intervention. A patient who is technically eligible for repair by age and aneurysm size might still be better served by conservative management if they are severely debilitated.

Where you live and your socioeconomic standing also shape outcomes. An analysis of English hospital data found that men from more deprived areas were more likely to present with a ruptured aneurysm rather than an elective intact repair, meaning they missed the window for a planned surgery. They were also more likely to need emergency admission for intact repairs. Post-repair mortality was higher in more deprived areas as well, though the gap narrowed with advancing age.³⁵ These are not biological differences; they are differences in access to screening, in the timeliness of referral, and in the management of related risk factors like smoking and high blood pressure.

Living With a Watched Aneurysm

Many people with small aneurysms are placed under surveillance, meaning regular ultrasound or CT scans every six to twelve months, with repair deferred until the aneurysm reaches threshold size or starts growing quickly. Psychologically, this is not always easy. A prospective study following patients approaching the surgical threshold found that overall quality of life, anxiety, and depression scores stayed relatively stable during surveillance, which is reassuring. However, women reported lower quality of life and higher anxiety than men, and patients who had a first-degree relative with an aneurysm carried roughly three times the risk of clinically significant anxiety.³⁶ Interestingly, anxiety and depression scores actually improved as patients approached the point of surgery, possibly because the uncertainty was about to end.

For those who experience an acute aortic event, the psychological toll can be heavier. A study of patients after acute type B aortic dissection found that two-thirds reported ongoing pain or discomfort, over half reported anxiety or depression, and about 20 percent scored high enough on a depression questionnaire to warrant clinical attention.³⁷ These numbers are a reminder that survival statistics do not tell the whole story. Even among patients who survive their aneurysm or dissection, the experience of living with a vulnerable aorta, and the limitations it can impose, carry their own weight. Addressing the psychological dimension alongside the surgical and medical management makes a material difference in how patients experience their lives after diagnosis.